B. Kevin Park

694 total citations
15 papers, 587 citations indexed

About

B. Kevin Park is a scholar working on Public Health, Environmental and Occupational Health, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, B. Kevin Park has authored 15 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 6 papers in Organic Chemistry and 6 papers in Computational Theory and Mathematics. Recurrent topics in B. Kevin Park's work include Malaria Research and Control (10 papers), Computational Drug Discovery Methods (6 papers) and HIV/AIDS drug development and treatment (4 papers). B. Kevin Park is often cited by papers focused on Malaria Research and Control (10 papers), Computational Drug Discovery Methods (6 papers) and HIV/AIDS drug development and treatment (4 papers). B. Kevin Park collaborates with scholars based in United Kingdom, Netherlands and Portugal. B. Kevin Park's co-authors include Paul M. O’Neill, James L. Maggs, Amy E. Mercer, James Chadwick, Stephen A. Ward, Gerald M. Cohen, Xiaoming Sun, R. C. STORR, Feodor Scheinmann and Andrew V. Stachulski and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

B. Kevin Park

15 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Kevin Park United Kingdom 12 297 212 212 142 86 15 587
Kristina Borstnik United States 10 352 1.2× 257 1.2× 172 0.8× 170 1.2× 39 0.5× 10 606
Amy E. Mercer United Kingdom 13 344 1.2× 226 1.1× 316 1.5× 161 1.1× 106 1.2× 15 806
Christine Latour France 17 289 1.0× 331 1.6× 152 0.7× 88 0.6× 43 0.5× 23 747
C Jaquet Switzerland 8 418 1.4× 185 0.9× 153 0.7× 119 0.8× 88 1.0× 12 645
Burkhard Fugmann Germany 16 261 0.9× 310 1.5× 167 0.8× 136 1.0× 68 0.8× 25 784
Jérôme Cazelles France 10 480 1.6× 253 1.2× 165 0.8× 207 1.5× 65 0.8× 10 676
Maria Leidenberger Germany 14 196 0.7× 269 1.3× 242 1.1× 85 0.6× 38 0.4× 16 683
Kirsten S. Smith United States 16 274 0.9× 414 2.0× 335 1.6× 133 0.9× 108 1.3× 26 898
Kaylene J. Raynes United Kingdom 8 372 1.3× 262 1.2× 122 0.6× 135 1.0× 58 0.7× 10 597
Suji Xie United States 17 557 1.9× 476 2.2× 306 1.4× 263 1.9× 56 0.7× 20 984

Countries citing papers authored by B. Kevin Park

Since Specialization
Citations

This map shows the geographic impact of B. Kevin Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Kevin Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Kevin Park more than expected).

Fields of papers citing papers by B. Kevin Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Kevin Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Kevin Park. The network helps show where B. Kevin Park may publish in the future.

Co-authorship network of co-authors of B. Kevin Park

This figure shows the co-authorship network connecting the top 25 collaborators of B. Kevin Park. A scholar is included among the top collaborators of B. Kevin Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Kevin Park. B. Kevin Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Copple, Ian M., Amy E. Mercer, James W. Firman, et al.. (2012). Examination of the Cytotoxic and Embryotoxic Potential and Underlying Mechanisms of Next-Generation Synthetic Trioxolane and Tetraoxane Antimalarials. Molecular Medicine. 18(7). 1045–1055. 11 indexed citations
2.
Chadwick, James, Michael E. Jones, Amy E. Mercer, et al.. (2010). Design, synthesis and antimalarial/anticancer evaluation of spermidine linked artemisinin conjugates designed to exploit polyamine transporters in Plasmodium falciparum and HL-60 cancer cell lines. Bioorganic & Medicinal Chemistry. 18(7). 2586–2597. 46 indexed citations
3.
Jones, Michael E., Amy E. Mercer, Paul A. Stocks, et al.. (2009). Antitumour and antimalarial activity of artemisinin–acridine hybrids. Bioorganic & Medicinal Chemistry Letters. 19(7). 2033–2037. 48 indexed citations
4.
Chadwick, James, Amy E. Mercer, B. Kevin Park, Richard Cosstick, & Paul M. O’Neill. (2008). Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells. Bioorganic & Medicinal Chemistry. 17(3). 1325–1338. 56 indexed citations
5.
Mercer, Amy E., James L. Maggs, Xiaoming Sun, et al.. (2007). Evidence for the Involvement of Carbon-centered Radicals in the Induction of Apoptotic Cell Death by Artemisinin Compounds. Journal of Biological Chemistry. 282(13). 9372–9382. 169 indexed citations
6.
O’Neill, Paul M., Feodor Scheinmann, Andrew V. Stachulski, James L. Maggs, & B. Kevin Park. (2001). Efficient Preparations of the β-Glucuronides of Dihydroartemisinin and Structural Confirmation of the Human Glucuronide Metabolite. Journal of Medicinal Chemistry. 44(9). 1467–1470. 30 indexed citations
7.
O’Neill, Paul M., Stephen Hindley, James L. Maggs, et al.. (2000). Synthesis, Antimalarial Activity, Biomimetic Iron(II) Chemistry, and in Vivo Metabolism of Novel, PotentC-10-Phenoxy Derivatives of Dihydroartemisinin. Journal of Medicinal Chemistry. 44(1). 58–68. 65 indexed citations
9.
Maggs, James L., et al.. (1999). Metabolism of the Antimalarial Endoperoxide Ro 42-1611 (Arteflene) in the Rat: Evidence for Endoperoxide Bioactivation. Journal of Pharmacology and Experimental Therapeutics. 289(1). 511–520. 11 indexed citations
10.
Park, B. Kevin, Paul M. O’Neill, James L. Maggs, & Munir Pirmohamed. (1998). Safety assessment of peroxide antimalarials: clinical and chemical perspectives. British Journal of Clinical Pharmacology. 46(6). 521–529. 42 indexed citations
11.
O’Neill, Paul M., R. C. STORR, & B. Kevin Park. (1998). Synthesis of the 8-aminoquinoline antimalarial 5-fluoroprimaquine. Tetrahedron. 54(18). 4615–4622. 25 indexed citations
12.
O’Neill, Paul M., James L. Maggs, Stephen A. Ward, et al.. (1997). The biomimetic iron-mediated degradation of arteflene (Ro-42-1611),an endoperoxide antimalarial: Implications for the mechanism of antimalarial activity. Tetrahedron Letters. 38(24). 4263–4266. 37 indexed citations
13.
O’Neill, Paul M., Shaun R. Hawley, R. C. STORR, Stephen A. Ward, & B. Kevin Park. (1996). The effect of fluorine substitution on the antimalarial activity of tebuquine. Bioorganic & Medicinal Chemistry Letters. 6(4). 391–392. 9 indexed citations
14.
O’Neill, Paul M., R. C. STORR, Shaun R. Hawley, et al.. (1996). Mechanism-Based Design of Parasite-Targeted Artemisinin Derivatives:  Synthesis and Antimalarial Activity of Benzylamino and Alkylamino Ether Analogues of Artemisinin. Journal of Medicinal Chemistry. 39(22). 4511–4514. 23 indexed citations
15.
O’Neill, Paul M., Malcolm D. Tingle, Roziahanim Mahmud, et al.. (1995). The effect of fluorine substitution on the haemotoxicity of Primaquine. Bioorganic & Medicinal Chemistry Letters. 5(20). 2309–2314. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026